Pages that link to "Q72590527"

The following pages link to Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study (Q72590527):

Displaying 49 items.

• Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients (Q24240955) (← links)
• Spontaneous bacterial peritonitis: a review of treatment options (Q24645324) (← links)
• Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis (Q24649027) (← links)
• Spontaneous bacterial peritonitis (Q24657984) (← links)
• Guidelines on the management of ascites in cirrhosis (Q24676541) (← links)
• Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen (Q26829236) (← links)
• Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver (Q27001540) (← links)
• Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis (Q28344827) (← links)
• Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study (Q33429259) (← links)
• Klebsiella pneumoniae septic arthritis in a cirrhotic patient with hepatocellular carcinoma (Q33631788) (← links)
• Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. (Q33781627) (← links)
• Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club (Q33836637) (← links)
• Bacteriologic study of cirrhotic patients with non-neutrocytic ascites (Q34290653) (← links)
• Clinical management of ascites and its complications (Q34374968) (← links)
• Management of cirrhotic ascites (Q34475601) (← links)
• Gut microbiota-related complications in cirrhosis (Q34499061) (← links)
• Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. (Q35936876) (← links)
• Pathophysiology, complications, and treatment of ascites (Q35962232) (← links)
• Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice (Q37257812) (← links)
• Severe sepsis in cirrhosis. (Q37626629) (← links)
• Therapeutic strategies and emergence of multiresistant bacterial strains (Q37791937) (← links)
• Immune Dysfunction and Infections in Patients With Cirrhosis (Q37852409) (← links)
• Management of bacterial infections in cirrhosis. (Q37980891) (← links)
• Drug therapies in liver disease. (Q38168180) (← links)
• A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient (Q40262179) (← links)
• The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications (Q40707686) (← links)
• Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis. (Q40744480) (← links)
• Practical recommendations for the treatment of ascites and its complications (Q40880332) (← links)
• Management of portal hypertension and its complications (Q41109702) (← links)
• When to use antibiotics in the cirrhotic patient? The evidence base (Q42406057) (← links)
• Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis (Q42689940) (← links)
• Diagnosis and therapy of ascites in liver cirrhosis (Q42707608) (← links)
• Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication? (Q42999711) (← links)
• Clinical features and outcome of spontaneous bacterial peritonitis in HIV-infected cirrhotic patients: a case-control study. (Q43000726) (← links)
• 6 years of the International Union of Societies of Immunology. Presidential report (Brighton 1974) (Q43787030) (← links)
• Treatment and prevention of ascitic fluid infection (Q44284068) (← links)
• Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications (Q44312518) (← links)
• Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients (Q44909810) (← links)
• Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis (Q53226480) (← links)
• Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients (Q61576388) (← links)
• Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality (Q61576542) (← links)
• Characterisation of bacteria in ascites—reporting the potential of culture-independent, molecular analysis (Q61963470) (← links)
• [Consensus on spontaneous bacterial peritonitis in liver cirrhosis: diagnosis, treatment, and prophylaxis] (Q73542378) (← links)
• Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients (Q74645207) (← links)
• Primary and secondary peritonitis: an update (Q77491776) (← links)
• [Spontaneous bacterial peritonitis] (Q77666629) (← links)
• [Infection during cirrhosis] (Q80052049) (← links)
• [How to treat and to prevent spontaneous bacterial peritonitis?] (Q80103226) (← links)
• Guidelines for Antibiotic Prescription in Intensive Care Unit (Q90086575) (← links)